<?xml version="1.0" encoding="UTF-8"?>
<p>The most common outpatient medications involved in significant DDIs (category 3 or 4) with the most recently approved DAA regimens, VEL/SOF (n = 58), GLE/PIB (n = 46), and ELB/GRZ (n = 73), were proton pump inhibitors (PPIs), metamizole, statins, and carvedilol (
 <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 6</xref>). More precise information on relevant DDIs and their respective mechanisms can be found in the Supplementary Data (
 <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 7</xref>).
</p>
